跳至主要内容
临床试验/NCT06447805
NCT06447805已完成不适用

"A Pilot Study Assessing Feasibility of a Randomized Trial Comparing the Effect of Early Double Sequential Defibrillation as Soon as Possible in OHCA With a Shockable Rhythm (VT/VF) Compared to Standard Defibrillation"

Karolinska Institutet5 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
5
主要终点
Cross-over

研究概览

简要总结

Some of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospective cluster randomized trial showed increased survival among (OHCA) patients in refractory VF using Double Sequential Defibrillation (DSD).

To evaluate feasibility and safety this randomized pilot trial will compare the effect of double defibrillation strategy initiated as soon as possible after the first defibrillation with continued resuscitation using standard defibrillation, in patients with Out of Hospital Cardiac arrest (OHCA). The results from this pilot trial will form the basis for design of a larger multicenter survival study.

详细描述

The Dubbel-D study is an academic, investigator initiated, open-label pilot study with a randomized controlled trial (RCT) design conducted in the prehospital emergency medical services, i.e. ambulance organizations. The trial will be conducted by participating ambulance units attending OHCA´s. These units will perform screening for inclusion, randomization, intervention or control treatment and initial follow-up.

In all cases of OHCA a defibrillator should always be attached with the standard pad placement, anterio-lateral (A-L) position first. This is in accordance with standard of care. If there is VT/VF or an automated external defibrillator (AED) suggests defibrillation, defibrillation should be performed, and immediate chest compressions resumed. Thereafter, the patient can be screened for inclusion. If two study specific defibrillators (Corpulse 3) on site and no exclusion criteria (age below 18 years, obvious pregnancy, known preexisting Do Not Attempt Resuscitation order) the patient can be included and randomized.

Randomization will be performed by drawing a scratch-card with concealed allocation that will be stored with the EMS defibrillators. All scratch-cards will be pre-randomized in a 3:1 ratio in blocks consisting of 4-8-12 and stratified by region and ambulance provider.

If the patient is randomized to the intervention group, the ambulance crew team will apply the second defibrillator with electrodes placed in the anterio-posterior (A-P) position as soon as possible. Defibrillation is performed by one person defibrillating both defibrillators in a sequential manner "Double Sequential Defibrillation" (DSD). All consecutive defibrillations will thereafter be performed with the DSD strategy until ROSC, termination of resuscitation or decision to move the patient to hospital.

If randomized to the control group, the ambulance crew team will continue Advanced Life Support (ACLS) in accordance with standard of care. Defibrillation is performed with standard electrode placement (A-L position) using a single defibrillator. If an AED is the first defibrillator attached to the patient, the ambulance crew should shift from an AED to their own manual defibrillator, but the mode of defibrillation should remain in A-L position and only one defibrillator should be used for each defibrillation and continue until ROSC, termination of resuscitation or decision to move the patient to hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Out-of-Hospital patients with Ventricular Fibrillation/ Ventricular Tachycardia at rhythm analysis after ambulance arrival and at least one defibrillation performed in standard (Antero-Lateral) position

排除标准

  • •Age below 18 years
  • •Obvious pregnancy
  • •Known preexisting Do Not Attempt Resuscitation order

研究组 & 干预措施

Double Sequential Defibrillation (DSD)

Experimental

If the patient is randomized to the DSD group, the ambulance crew team will apply the second defibrillator with electrodes placed in the A-P position as soon as possible.

Defibrillation is performed by one person defibrillating both defibrillators in a sequential manner "Double Sequential Defibrillation" (DSD). All consecutive defibrillations will thereafter be performed with the DSD strategy until ROSC, termination of resuscitation or decision to move the patient to hospital.

干预措施: Double Sequential Defibrillation (DSD) (Device)

Standard defibrillation

Active Comparator

If the patient is randomized to the standard defibrillation group, the ambulance crew team will continue Advanced life support in accordance with standard of care and continue to perform standard defibibrillation using one defibrillator. All consecutive defibrillations will thereafter be performed with the standard defibrillation strategy until ROSC, termination of resuscitation or decision to move the patient to hospital.

干预措施: Standard defibrillation (Device)

结局指标

主要结局

Cross-over

时间窗: day 1

Among patients randomized to standard, proportion that received DSD (target \< 10%)

Safety of CPR during double sequential external defibrillation

时间窗: day 1

Chest compression fraction (hands off time during CPR, target \> 80% in both groups)

Adherence to double sequential external defibrillation (DSD)

时间窗: day 1

Among patients randomized to DSD, proportion that received DSD (target \> 80%)

Feasibility of double sequential external defibrillation (DSD)

时间窗: day 1

Proportion of eligible patients included and randomized (target \> 80%)

Feasibility of early double sequential external defibrillation (DSD)

时间窗: day 1

Number of EMS defibrillations prior to randomization (target \> 80% before third defibrillation)

Safety of double sequential external defibrillation

时间窗: day 1

Major adverse events (e.g. defibrillator malfunction)

次要结局

  • 30 day survival(day 30)
  • Return of spontaneous circulation (ROSC)(day 1)
  • Survival to discharge(day 1-180)
  • Survival to hospital admission(day 1)
  • Neurological function at 30 days(day 30)
  • Number of defibrillations to sustained ROSC(day 1)
  • Neurological function and Health related Quality of life at 90 and 180 days(day 90 and 180)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gabriel Riva

Principal Investigator, M.D., Ph.D. Center for resuscitation Scinence

Karolinska Institutet

研究点 (5)

Loading locations...

相似试验